Amplification and over-expression of cyclin D1 [4], alterations in the p53 and p16 pathways [5], [6], and mutations of p53 [7]–[9] and retinoblastoma [10] are involved in development of ESCC. Here, TP53 is linked to esophageal squamous cell carcinoma.